Chrysin targets myeloid-derived suppressor cells and enhances tumour response to anti-PD-1 immunotherapy

Clin Transl Med. 2022 Sep;12(9):e1019. doi: 10.1002/ctm2.1019.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Flavonoids / pharmacology
  • Flavonoids / therapeutic use
  • Humans
  • Immunologic Factors
  • Immunotherapy
  • Myeloid-Derived Suppressor Cells*
  • Neoplasms* / drug therapy

Substances

  • Flavonoids
  • Immunologic Factors
  • chrysin